R
Raul D. Santos
Researcher at University of São Paulo
Publications - 463
Citations - 21660
Raul D. Santos is an academic researcher from University of São Paulo. The author has contributed to research in topics: Familial hypercholesterolemia & Medicine. The author has an hindex of 56, co-authored 404 publications receiving 16997 citations. Previous affiliations of Raul D. Santos include Albert Einstein Hospital.
Papers
More filters
Journal ArticleDOI
Liver histology during Mipomersen therapy for severe hypercholesterolemia
Nikroo Hashemi,Robert D. Odze,Mary P. McGowan,Mary P. McGowan,Raul D. Santos,Erik S.G. Stroes,David E. Cohen +6 more
TL;DR: These findings suggest that hepatic steatosis resulting from mipomersen is distinct from nonalcoholic steatohepatitis, which could in turn lead to fibrosis and cirrhosis over time.
Journal ArticleDOI
Hyperlipidemia related to the use of HIV-protease inhibitors: natural history and results of treatment with fenofibrate.
Bruno Caramelli,Claudia Bernoche,Ana Marli Christovam Sartori,Andrei C. Sposito,Raul D. Santos,Maristela C. Monachini,Tania Mara Varejão Strabelli,Davi Uip +7 more
TL;DR: Hyperlipidemia is common during the treatment of HIV with protease inhibitors, and fenofibrate appears to be an effective and safe choice for its treatment.
Journal ArticleDOI
Targeting PCSK9 for therapeutic gains: Have we addressed all the concerns?
TL;DR: This review appraises the different lipid lowering strategies targeting PCSK9 in light of the protein's different pleiotropic functions and delineates the key areas that require further examination, to ensure the long-term safety of the above lipid-lowering strategies.
Journal ArticleDOI
The progression and impact of vascular calcification in peritoneal dialysis patients.
Adriano Luiz Ammirati,Maria Aparecida Dalboni,Miguel Cendoroglo,Sergio Antonio Draibe,Raul D. Santos,Marcio H. Miname,Maria Eugênia Fernandes Canziani +6 more
TL;DR: Determining CAC provides important prognostic data in peritoneal dialysis patients, and baseline calcium score and disturbances in glucose, mineral, and lipid metabolism were indicative of higher risk of CAC progression in this population.
Journal ArticleDOI
Low- and high-density lipoprotein cholesterol goal attainment in dyslipidemic women: The Lipid Treatment Assessment Project (L-TAP) 2
Raul D. Santos,David D. Waters,Lisa Tarasenko,Michael Messig,J. Wouter Jukema,Jean Ferrières,Juan Verdejo,Cheng Wen Chiang +7 more
TL;DR: Cholesterol treatment has improved substantially since the original L-TAP a decade ago, however, high-risk women are undertreated compared to men, and a substantial opportunity remains to reduce their cardiovascular risk.